Genetesis

Genetesis is a rapidly growing medical technology company redefining the way patients with a risk of myocardial ischemia and coronary artery disease are clinically diagnosed, monitored and screened.

Genetesis headquartered in United States, North America, operates in the Health Care, Medical Device, Health Diagnostics, Emergency Medicine sector. The company focuses on Health Care and has secured $4.6B in funding across 128 round(s). With a team of 11-50 employees, Genetesis is actively contributing to advancements in Health Care. Their latest funding round, Seed Round - Genetesis, raised $1.2M. Discover more about their projects, partnerships, and impact on our platform.